Cargando…
CB(2) Receptor Agonists Protect Human Dopaminergic Neurons against Damage from HIV-1 gp120
Despite the therapeutic impact of anti-retroviral therapy, HIV-1-associated neurocognitive disorder (HAND) remains a serious threat to AIDS patients, and there currently remains no specific therapy for the neurological manifestations of HIV-1. Recent work suggests that the nigrostriatal dopaminergic...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798286/ https://www.ncbi.nlm.nih.gov/pubmed/24147028 http://dx.doi.org/10.1371/journal.pone.0077577 |